Optimization of Synergistic Combination Regimens Against Carbapenem- And Aminoglycoside-Resistant Clinical Pseudomonas Aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01011-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Carbapenem Resistance Mechanisms in Pseudomonas Aeruginosa Clinical Isolates

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

The SYNERGISTIC EFFECT OF SOME ANTIBIOTICS AGAINST CLINICAL ISOLATES OF Pseudomonas Aeruginosa

Basrah Journal of Veterinary Research
2009English

Antimicrobial Activities and Mechanisms of Carbapenem Resistance in Clinical Isolates of Carbapenem-Resistant Pseudomonas Aeruginosa and Acinetobacter Spp.

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
2001English

Associations Between Carbapenem Use, Carbapenem-Resistant Pseudomonas Aeruginosa, and Carbapenem-Resistant Acinetobacter Baumannii

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2013English

Investigation of OprD Porin Protein Levels in Carbapenem-Resistant Pseudomonas Aeruginosa Isolates

Jundishapur Journal of Microbiology
Infectious DiseasesMicrobiology
2015English

Mutational and Acquired Carbapenem Resistance Mechanisms in Multidrug Resistant Pseudomonas Aeruginosa Clinical Isolates From Recife, Brazil

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2015English

Pharmacokinetic/Pharmacodynamic Investigation of Colistin Against Pseudomonas Aeruginosa Using an in Vitro Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Synergistic Activity of Colistin and Rifampin Combination Against Multidrug-Resistant Acinetobacter Baumannii in an in Vitro Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), Against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas Aeruginosa Clinical Strains

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy